Search research articles
Contact Us
Filters
Showing results (1-10 of 515) with videos related to
Page
of 52
Sort By:
The American Journal of Gastroenterology
|
December 1, 1993
Cedemin, a Ginkgo biloba extract, should not be considered as a PAF antagonist
P Braquet
Advances in Prostaglandin, Thromboxane, and Leukotriene Research
|
January 1, 1986
Proofs of involvement of PAF-acether in various immune disorders using BN 52021 (ginkgolide B): a powerful PAF-acether antagonist isolated from Ginkgo biloba L
P Braquet
Agents and Actions
|
January 1, 1991
New trends in PAF antagonist research: a new series of potent hetrapazine-derived PAF antagonists
P Braquet, A Esanu
Critical Reviews in Oncology/Hematology
|
March 1, 1995
Advances in either phospholipids treatment of cancer
P Principe, P Braquet
Agents and Actions. Supplements
|
January 1, 1995
The similarity in action of hypoxia and platelet-activating factor on smooth muscle cells of coronary arteries: possible explanation for hypoxic coronary spasm development
A Soloviev, P Braquet
Presse Medicale (Paris, France : 1983)
|
April 16, 1988
[The role of the platelet-activating factor (PAF-acether) in renal pathology]
E Pirotzky, P Braquet
Contributions to Nephrology
|
January 1, 1984
Interaction between K+-transport, membrane potential and prostacyclin generation in the regulation of natriuresis
P Braquet, R Garay
Progress in Biochemical Pharmacology
|
January 1, 1988
PAF-acether and kidney pathology
E Pirotzky, P Braquet
Drugs Under Experimental and Clinical Research
|
January 1, 1992
Cellular electrophysiological effects of platelet-activating factor (PAF) and its antagonist BN 52021 in cardiac preparations
V Kecskemeti, P Braquet
Progress in Medicinal Chemistry
|
January 1, 1990
Antagonists of platelet-activating factor: chemistry, pharmacology and clinical applications
D Hosford, P Braquet
Page
of 52
Search research articles
Search
Showing results (1-10 of 515) with videos related to
Sort By:
Page
of 52
The American Journal of Gastroenterology
|
December 1, 1993
Cedemin, a Ginkgo biloba extract, should not be considered as a PAF antagonist
P Braquet
Advances in Prostaglandin, Thromboxane, and Leukotriene Research
|
January 1, 1986
Proofs of involvement of PAF-acether in various immune disorders using BN 52021 (ginkgolide B): a powerful PAF-acether antagonist isolated from Ginkgo biloba L
P Braquet
Agents and Actions
|
January 1, 1991
New trends in PAF antagonist research: a new series of potent hetrapazine-derived PAF antagonists
P Braquet, A Esanu
Critical Reviews in Oncology/Hematology
|
March 1, 1995
Advances in either phospholipids treatment of cancer
P Principe, P Braquet
Agents and Actions. Supplements
|
January 1, 1995
The similarity in action of hypoxia and platelet-activating factor on smooth muscle cells of coronary arteries: possible explanation for hypoxic coronary spasm development
A Soloviev, P Braquet
Presse Medicale (Paris, France : 1983)
|
April 16, 1988
[The role of the platelet-activating factor (PAF-acether) in renal pathology]
E Pirotzky, P Braquet
Contributions to Nephrology
|
January 1, 1984
Interaction between K+-transport, membrane potential and prostacyclin generation in the regulation of natriuresis
P Braquet, R Garay
Progress in Biochemical Pharmacology
|
January 1, 1988
PAF-acether and kidney pathology
E Pirotzky, P Braquet
Drugs Under Experimental and Clinical Research
|
January 1, 1992
Cellular electrophysiological effects of platelet-activating factor (PAF) and its antagonist BN 52021 in cardiac preparations
V Kecskemeti, P Braquet
Progress in Medicinal Chemistry
|
January 1, 1990
Antagonists of platelet-activating factor: chemistry, pharmacology and clinical applications
D Hosford, P Braquet
Page
of 52